The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer.
- Author:
	        		
		        		
		        		
			        		Jian-hui ZHANG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Yan LI
			        		
			        		;
		        		
		        		
		        		
			        		Rui WANG
			        		
			        		;
		        		
		        		
		        		
			        		Mario SARBIA
			        		
			        		;
		        		
		        		
		        		
			        		Wei GUO
			        		
			        		;
		        		
		        		
		        		
			        		Deng-gui WEN
			        		
			        		;
		        		
		        		
		        		
			        		Li-zhen WEI
			        		
			        		;
		        		
		        		
		        		
			        		Zhi-feng CHEN
			        		
			        		;
		        		
		        		
		        		
			        		Gang KUANG
			        		
			        		;
		        		
		        		
		        		
			        		Li-wei ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Ming HE
			        		
			        		;
		        		
		        		
		        		
			        		Ming-li WU
			        		
			        		;
		        		
		        		
		        		
			        		Shi-jie WANG
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Esophageal Neoplasms; genetics; Genetic Predisposition to Disease; Genotype; Humans; NAD(P)H Dehydrogenase (Quinone); genetics; Polymorphism, Genetic
 - From: Chinese Journal of Medical Genetics 2003;20(6):544-546
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo investigate the association of the NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with susceptibility to esophageal squamous cell carcinoma (ESCC) in a northern Chinese population.
METHODSThe NQO1 C609T genotypes were determined by polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP) analysis in 193 patients with ESCC and 141 unrelated healthy controls.
RESULTSThe frequency of the T allele (null) among ESCC patients was significantly higher than that among healthy controls (Chi-square=4.86, P=0.028). The NQO1 C/C and C/T genotype distribution among ESCC patients was not significantly different from that among healthy controls (Chi-square= 2.27 and 0.127; P=0.132 and 0.721, respectively). However, the T/T genotype frequency among ESCC patients was significantly higher than that among healthy controls (Chi-square=4.39, P=0.036). The NQO1 T/T genotype significantly increased the risk for developing ESCC, compared to the combination of C/C and C/T genotypes, with the adjusted odds ratio (OR) of 1.81 (95%CI: 1.04-3.15). This increased susceptibility exhibited pronouncedly in patients with family history of upper gastrointestinal cancers (adjusted OR=2.22, 95%CI 1.18-4.17).
CONCLUSIONDetermination of the NQO1 C609T genotype may be used as a stratification marker to predicate high-risk individuals for ESCC.
 
            